Ophthalmic Education:

Principles and Guidelines of a Curriculum for Education of the Ophthalmic Specialist: Appendix 1: Silicone Study

On this page:

• Recommended Reading
  
  
• Additional Background Reading

Recommended Reading

Abrams GW, Azen SP, McCuen BW, 2nd et al. Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11. Arch Ophthalmol 1997; 115: 335-344

McCuen BW 2nd, Azen SP, Stern W et al. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 3.
Retina 1993; 13: 279-284

(No authors listed). Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1. Arch Ophthalmol 1992; 110: 770-779

(No authors listed). Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol 1987; 105: 1499-1507

(No authors listed). Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 2. Arch Ophthalmol 1992; 110: 780-792

Lean JS, Stern WH, Irvine AR, Azen SP. Classification of proliferative vitreoretinopathy used in the silicone study. The Silicone Study Group. Ophthalmology 1989; 96: 765-771

Brown GC. Brown MM. Sharma S. Busbee B. Landy J. A cost-utility analysis of interventions for severe proliferative vitreoretinopathy. Am J Ophthalmol 2002; 133: 365-372

Pastor JC. Proliferative vitreoretinopathy: an overview. Surv Ophthalmol 1998; 43: 3-18

Additional Background Reading

Diddie KR, Azen SP, Freeman HM et al. Anterior proliferative vitreoretinopathy in the silicone study. Silicone Study Report Number 10. Ophthalmology 1996; 103: 1092-1099

Lean J, Azen SP, Lopez PF et al. The prognostic utility of the Silicone Study Classification System. Silicone Study Report 9. Silicone Study Group. Arch Ophthalmol 1996; 114: 286-292

Abrams GW, Azen SP, Barr CC et al. The incidence of corneal abnormalities in the Silicone Study. Silicone Study Report 7. Arch Ophthalmol 1995; 113: 764-769

Cox MS, Azen SP, Barr CC et al. Macular pucker after successful surgery for proliferative vitreoretinopathy. Silicone Study Report 8. Ophthalmology 1995; 102: 1884-1891

Hutton WL, Azen SP, Blumenkranz MS et al. The effects of silicone oil removal. Silicone Study Report 6. Arch Ophthalmol 1994; 112: 778-785

Peyman GA, Greve MD, Millsap CM. Silicone oil vs perfluoropropane gas as a postoperative retinal tamponade. Arch Ophthalmol 1994; 112: 728-729; Reply by McCuen BW, Azen SP: 729

Chan CK. Reports by the Silicone Study Group. Arch Ophthalmol 1993; 111: 428; author reply 429

Le Mer Y. Reports by the Silicone Study Group. Arch Ophthalmol 1993; 111: 429

Barr CC, Lai MY, Lean JS et al. Postoperative intraocular pressure abnormalities in the Silicone Study. Silicone Study Report 4. Ophthalmology 1993; 100: 1629-1635

Blumenkranz MS, Azen SP, Aaberg T et al. Relaxing retinotomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 5. The Silicone Study Group. Am J Ophthalmol 1993; 116: 557-564

Azen SP, Boone DC, Barlow W et al. Methods, statistical features, and baseline results of a standardized, multicentered ophthalmologic surgical trial: the Silicone Study. Control Clin Trials 1991; 12: 438-455

Barlow W, Azen S. The effect of therapeutic treatment crossovers on the power of clinical trials. The Silicone Study Group. Control Clin Trials 1990; 11: 314-326

Azen SP, Irvine AR, Davis MD et al. The validity and reliability of photographic documentation of proliferative vitreoretinopathy. Ophthalmology 1989; 96: 352-357

Boone DC, Lai M, Azen S, Silicone Study Group. Clinical judgment and centralized data management. Control Clin Trials 1989: 339

Irvine AR. Photographic documentation and grading of PVR, in Freeman HM, Tolentino FI (eds). Proliferative Vitreoretinopathy, New York, Springer-Verlag 1989: 105-109

Stern WH, Lean JS, Silicone Study Group. Intraocular silicone oil versus gas in the management of proliferative vitreoretinopathy (PVR): A multicenter clinical study, in Freeman HM, Tolentino FI (eds). Proliferative Vitreoretinopathy. New York, Springer-Verlag, 1989

Glaser BM. Silicone oil for proliferative vitreoretinopathy. Does it help or hinder? Arch Ophthalmol 1988; 106: 323-324

Lean JS. Changing attitudes in United States to use of intravitreal silicone. Jpn J Ophthalmol 1987; 31: 132-137

(No authors listed). Proliferative vitreoretinopathy (editorial). The Silicone Study Group. Am J Ophthalmol 1985; 99: 593-595

Campochiaro PA. The Silicone Study. A small piece of the PVR puzzle is put into place. Arch Ophthalmol 1997; 115: 407-408

Haller JA, Campochiaro PA. Oil and gas on troubled waters. The proliferative vitreoretinopathy studies. Arch Ophthalmol 1992; 110: 768-769

Next: Appendix 1: Submacular Surgery Trials (SST)

Also see: Table of Contents of the Principles and Guidelines of a Curriculum for Education of the Ophthalmic Specialist